The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Is IDO1 an adequate target for treatment in glioblastoma?
 
Christian Andre Mariño Siancas
No Relationships to Disclose
 
Ainhoa Hernandez Gonzalez
Consulting or Advisory Role - Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Roche
 
Marta Domenech
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Roche
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca Spain
 
Anna Esteve-Codina
No Relationships to Disclose
 
Oriol Arpi
No Relationships to Disclose
 
Francesc Alameda
No Relationships to Disclose
 
Estela Pineda
No Relationships to Disclose
 
Sviatoslav Chekhun
No Relationships to Disclose
 
Assumpcio Lopez Paradis
No Relationships to Disclose
 
Sonia Del Barco
No Relationships to Disclose
 
Nuria de la Iglesia
Research Funding - Grifols (Inst)
 
Oscar Gallego Rubio
No Relationships to Disclose
 
Carlos Mesia
No Relationships to Disclose
 
Mar Mallo
No Relationships to Disclose
 
Anna Esteve
No Relationships to Disclose
 
Cristina Carrato
No Relationships to Disclose
 
Carmen Balana
Consulting or Advisory Role - Abbvie; Celgene
 
María Martínez-García
Consulting or Advisory Role - Pierre Fabre; Roche; Seagen
Travel, Accommodations, Expenses - Pfizer; Roche